We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BKR:NASDAQBaker Hughes Company Analysis

Data as of 2026-03-10 - not real-time

$60.10

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Baker Hughes is trading at $60.10, comfortably above its 50‑day SMA ($55.97) and 200‑day SMA ($47.27) but just shy of the 20‑day SMA ($62.02), signaling a short‑term pull‑back within a longer‑term uptrend. The RSI sits at 49.6, indicating neutral momentum, while the MACD histogram remains negative, suggesting lingering bearish pressure. Volume is rising and the price is anchored above the identified support of $58.43, with upside potential toward the $67 resistance level. The Fear & Greed Index at 75.9 (“Extreme Greed”) reflects strong market optimism, yet the 30‑day volatility of over 30% and a beta near 1.1 highlight notable price swings.
Fundamentally, BKR posts modest revenue growth (0.3%), solid ROE (14.5%), and a healthy dividend yield (1.53%) backed by a 35% payout ratio, indicating dividend sustainability. The forward P/E of 20.66 is above the industry average of 20.57, suggesting slight overvaluation, while the DCF fair value aligns closely with the current price, resulting in a neutral upside/downside estimate of ~2%. Recent material news includes a quarterly dividend declaration and the successful pricing of a $6.5 billion debt offering, reinforcing cash flow discipline but also adding leverage to an already high debt‑to‑equity profile.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near established support at $58.43
  • Increasing volume supporting a potential bounce
  • MACD bearish divergence cautioning against a quick rally

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Bullish alignment above 50‑day and 200‑day SMAs
  • Sustainable dividend yield and solid cash flow generation
  • Potential upside to resistance near $67

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Energy transition and cyclical oilfield services exposure
  • Elevated leverage from recent $6.5 billion debt issuance
  • Consistent dividend policy and respectable ROE

Key Metrics & Analysis

Financial Health

Revenue Growth0.30%
Profit Margin9.33%
P/E Ratio23.1
ROE14.55%
ROA5.54%
Debt/Equity35.26
P/B Ratio3.1
Op. Cash Flow$3.8B
Free Cash Flow$1.1B
Industry P/E20.6

Technical Analysis

TrendBullish
RSI49.6
Support$58.43
Resistance$67.00
MA 20$62.02
MA 50$55.97
MA 200$47.27
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89

Valuation

Fair Value$12.96
Target Price$61.38
Upside/Downside2.13%
GradeFair
TypeBlend
Dividend Yield1.53%

Risk Assessment

Beta1.12
Volatility30.27%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.